These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 25922405)

  • 1. Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods.
    Rashid MU; Zaura E; Buijs MJ; Keijser BJ; Crielaard W; Nord CE; Weintraub A
    Clin Infect Dis; 2015 May; 60 Suppl 2():S77-84. PubMed ID: 25922405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacin.
    Rashid MU; Weintraub A; Nord CE
    Anaerobe; 2015 Feb; 31():72-7. PubMed ID: 25445201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota.
    Stewardson AJ; Gaïa N; François P; Malhotra-Kumar S; Delémont C; Martinez de Tejada B; Schrenzel J; Harbarth S; Lazarevic V;
    Clin Microbiol Infect; 2015 Apr; 21(4):344.e1-11. PubMed ID: 25658522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successional Dynamics in the Gut Microbiome Determine the Success of
    Jurburg SD; Cornelissen JJBWJ; de Boer P; Smits MA; Rebel JMJ
    Front Cell Infect Microbiol; 2019; 9():271. PubMed ID: 31448240
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor.
    Card RM; Mafura M; Hunt T; Kirchner M; Weile J; Rashid MU; Weintraub A; Nord CE; Anjum MF
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4410-6. PubMed ID: 25987611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota.
    Rashid MU; Rosenborg S; Panagiotidis G; Löfdal KS; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2015 Jul; 46(1):60-5. PubMed ID: 25979639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.
    Haak BW; Lankelma JM; Hugenholtz F; Belzer C; de Vos WM; Wiersinga WJ
    J Antimicrob Chemother; 2019 Mar; 74(3):782-786. PubMed ID: 30418539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome Resilience despite a Profound Loss of Minority Microbiota following Clindamycin Challenge in Humanized Gnotobiotic Mice.
    Liu L; Kirst ME; Zhao L; Li E; Wang GP
    Microbiol Spectr; 2022 Feb; 10(1):e0196021. PubMed ID: 35019780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea.
    Sepp E; Stšepetova J; Smidt I; Rätsep M; Kõljalg S; Lõivukene K; Mändar R; Jaanimäe L; Löhr IH; Natås OB; Naaber P
    Anaerobe; 2011 Dec; 17(6):407-9. PubMed ID: 21549208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces.
    Zaura E; Brandt BW; Teixeira de Mattos MJ; Buijs MJ; Caspers MP; Rashid MU; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJ; Crielaard W
    mBio; 2015 Nov; 6(6):e01693-15. PubMed ID: 26556275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culturomics and pyrosequencing evidence of the reduction in gut microbiota diversity in patients with broad-spectrum antibiotics.
    Dubourg G; Lagier JC; Robert C; Armougom F; Hugon P; Metidji S; Dione N; Dangui NP; Pfleiderer A; Abrahao J; Musso D; Papazian L; Brouqui P; Bibi F; Yasir M; Vialettes B; Raoult D
    Int J Antimicrob Agents; 2014 Aug; 44(2):117-24. PubMed ID: 25063078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro study to assess the impact of tetracycline on the human intestinal microbiome.
    Jung JY; Ahn Y; Khare S; Gokulan K; Piñeiro SA; Cerniglia CE
    Anaerobe; 2018 Feb; 49():85-94. PubMed ID: 29294359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China.
    Dong D; Ni Q; Wang C; Zhang L; Li Z; Jiang C; EnqiangMao ; Peng Y
    BMC Infect Dis; 2018 May; 18(1):207. PubMed ID: 29724187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin.
    Heinsen FA; Knecht H; Neulinger SC; Schmitz RA; Knecht C; Kühbacher T; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
    Gut Microbes; 2015 Jul; 6(4):243-54. PubMed ID: 26178862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii.
    Barc MC; Charrin-Sarnel C; Rochet V; Bourlioux F; Sandré C; Boureau H; Doré J; Collignon A
    Anaerobe; 2008 Oct; 14(4):229-33. PubMed ID: 18511310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
    Tomkovich S; Stough JMA; Bishop L; Schloss PD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial.
    Pallav K; Dowd SE; Villafuerte J; Yang X; Kabbani T; Hansen J; Dennis M; Leffler DA; Newburg DS; Kelly CP
    Gut Microbes; 2014 Jul; 5(4):458-67. PubMed ID: 25006989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.